ZYDUS LIFESCIENCES
Back to Balance Sheet
|
ZYDUS LIFESCIENCES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹193 Cr | ₹-725 Cr | ₹-194 Cr | ₹19 Cr | ₹2,854 Cr |
What is the latest Total Non-Current Liabilities ratio of ZYDUS LIFESCIENCES ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹193 Cr |
Mar2023 | ₹-725 Cr |
Mar2022 | ₹-194 Cr |
Mar2021 | ₹19 Cr |
Mar2020 | ₹2,854 Cr |
How is Total Non-Current Liabilities of ZYDUS LIFESCIENCES Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-725 Cr | Negative | |
Mar2022 | ₹-194 Cr | Negative | |
Mar2021 | ₹19 Cr | -99.32 | |
Mar2020 | ₹2,854 Cr | - |
Compare Total Non-Current Liabilities of peers of ZYDUS LIFESCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ZYDUS LIFESCIENCES | ₹82,719.7 Cr | -4.4% | -7.5% | -11.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹406,123.0 Cr | 0.2% | 1% | 6.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹152,844.0 Cr | 6.8% | 1.6% | 53.3% | Stock Analytics | |
CIPLA | ₹120,860.0 Cr | 4.4% | 2.9% | 4.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹109,020.0 Cr | -0.7% | 4% | 25.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,755.1 Cr | 4.6% | 4.9% | -6.2% | Stock Analytics |
ZYDUS LIFESCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ZYDUS LIFESCIENCES | -4.4% |
-7.5% |
-11.1% |
SENSEX | 5.3% |
4% |
3.2% |
You may also like the below Video Courses